Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer

Details for Australian Patent Application No. 2010212590 (hide)

Owner AstraZeneca AB

Inventors Bradbury, Robert Hugh; Carr, Gregory Richard; Rabow, Alfred Arthur; Rao Korupoju, Srinivasa; Tumma, Harikrishna

Agent Davies Collison Cave

Pub. Number AU-A-2010212590

PCT Pub. Number WO2010/092371

Priority 61/151,221 10.02.09 US; 61/187,766 17.06.09 US

Filing date 8 February 2010

Wipo publication date 19 August 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/092371 Priority application(s): WO2010/092371

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212591-Animal tag, strip of animal tags and applicator

2010212580-Stable pharmaceutical composition for atherosclerosis